Acta Scientific Dental Sciences (ASDS)(ISSN: 2581-4893)

Review Article Volume 5 Issue 9

OSMF: Hearing Forfeiture by Fibrosis

Sreepradha C1*, Vaishali MR2, Maria Priscilla David3 and Roopashri G2

1Assistant Professor, Department of Oral and Medicine and Radiology, GDCRI, Bellary, India
2Reader, Department of Oral and Medicine and Radiology, M R Ambedkar Dental College and Hospital, Bangalore, India
3Professor and HOD, Department of Oral and Medicine and Radiology, M R Ambedkar Dental College and Hospital, Bangalore, India

*Corresponding Author: Sreepradha C, Assistant Professor, Department of Oral and Medicine and Radiology, GDCRI, Bellary, India.

Received: August 13, 2021; Published: August 28, 2021

Abstract

  Oral squamous cell carcinoma has been ranked at the sixth position amongst the malignant neoplasms, with primarily the incidence of a precursor/pre-cancer such as oral leukoplakia, oral erythroplakia oral submucous fibrosis. The aetiology of OSMF is multifactorial and embraces local factors as well as systemic factors seen to affect retromolar region, buccal mucosa, followed by palatal fauces and uvula, soft palate, tongue later trailed by the labial mucosa. Clinical features include tongue stiffness, blanched mucosa, fibrosis, depigmented gingiva, rubbery soft palate with decreased mobility and blanched and atrophic tonsils, and shrunken bud like uvula with impairment of activities such as eating as well as other functional activities. Impaired hearing assessment is a part of the diagnostic protocol and is the most ignored part of diagnosis. Tympanometry and audiometry form a part of the hearing diagnostic tools and should be made a part of the same.

Keywords: Oral Squamous Cell Carcinoma; Oral Submucous Fibrosis; Tympanometry; Inflammation; Disease; Audiometry

References

  1. S Gokul., et al. “Oxidant–antioxidant status in oral squamous cell carcinoma patients”. Oral Diseases 16 (2010): 29-33.
  2. Gurkan Yardimci., et al. “Precancerous lesions of oral mucosa”. The World Journal of Clinical Cases12 (2014): 866-872.
  3. Kumar S., et al. “Oral submucous fibrosis – revisited”. Annals of Dental Specialty2 (2014).
  4. Wollina U., et al. “Oral submucous fibrosis: an update”. Clinical, Cosmetic and Investigational Dermatology (2015): 8.
  5. Ongole RK and Praveen BN. “Textbook of Oral Medicine and Oral Diagnosis and Oral Radiology, 2nd edition”. Elsevier Inc (2014): 283-289.
  6. Michael Glick., et al. “Burket’s Oral Medicine”. 12th People medical publishing house-USA (2015): 103-104.
  7. Tilakaratne W M., et al. “Intralesional corticosteroids as treatment for restricted mouth opening in oral submucous fibrosis”. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology 122 (2016): 224-231.
  8. Jena AJ and Das SR. “A Review of Treatment Modalities in Oral Submucous Fibrosis”. International Journal of Pharmaceutical Sciences Review and Research 21 (2016): 128-130.
  9. Arakeri G and Brennan P. “Oral submucous fibrosis: an overview of the aetiology and pathogenesis, classification and principles of management”. British Journal of Oral and Maxillofacial Surgery 51 (2013): 587-593.
  10. Burket L., et al. “Burket's oral medicine”. Hamilton, Ont.: BC Decker 84 (2015): 98-117.
  11. Gupta SC., et al. “Histological changes to palatal and paratubal Muscles in oral submucous fibrosis”. The Journal of Laryngology and Otology 114 (2000): 947-950.
  12. Misra SP., et al. “Oesophageal sub epithelial fibrosis: an extension of oral submucosal fibrosis”. Postgraduate Medical Journal 74 (1998): 733-736.
  13. Parvathi Devi., et al. “Evaluation of hearing deficit in patients with oral submucous fibrosis”. Journal of Oral Science2 (2015): 109-113.
  14. Gupta SC., et al. “Oral submucous fibrosis with its possible effect on eustachian tube functions: a tympanometric study”. Indian Journal of Otolaryngology and Head and Neck Surgery 56 (2004): 183-185.
  15. Chaudhary MS., et al. “Evaluation of hearing efficiency in patients with oral submucous fibrosis”. Otolaryngology (2013).
  16. M Ashwini Kumar., et al. “Hyperbaric Oxygen Therapy in the Treatment of Oral Submucous Fibrosis”. Journal of Clinical and Diagnostic Research5 (2015): ZE01-ZE04.

Citation

Citation: Sreepradha C., et al. “OSMF: Hearing Forfeiture by Fibrosis”. Acta Scientific Dental Sciences 5.9 (2021): 165-168.

Copyright

Copyright: © 2021 Sreepradha C., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor0.810

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US